Dhaka, Sept. 24 -- Chief Adviser's Special Assistant on Finance Ministry, Anisuzzaman Chowdhury, on Tuesday reassured that Bangladesh's graduation from the Least Developed Country (LDC) category will not lead to higher medicine prices.

"Many people worry that once Bangladesh leaves the LDC group in 2026, the prices of medicines will rise sharply. In reality, the impact will be very limited," he told journalists.He explained that medicines which Bangladesh imports but does not manufacture domestically are unrelated to the LDC graduation issue.

"Even for drugs that carry intellectual property rights but are already being produced in Bangladesh, we are not bound to enforce those rights under the World Trade Organization (WTO) framework," h...